NanoViricides, Inc. (NNVC)

NYSEAMERICAN: NNVC · Real-Time Price · USD

1.330

+0.020 (1.53%)

Aug 21, 2026, 4:00 PM EDT - Market closed

NanoViricides Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Selling, General & Admin	3.6	4.04	3.08	2.55	2.33	2.63
Research & Development	4.58	5.55	5.44	6.39	5.78	6.11
Operating Expenses	8.18	9.59	8.52	8.94	8.11	8.74
Operating Income	-8.18	-9.59	-8.52	-8.94	-8.11	-8.74
Interest Expense	-	-0	-0.05	-0	-0.01	-0.09
Interest & Investment Income	0.08	0.12	0.27	0.36	0.01	0.01
EBT Excluding Unusual Items	-8.09	-9.47	-8.29	-8.59	-8.11	-8.82
Gain (Loss) on Sale of Assets	-	-	-	-	-	-0
Pretax Income	-8.09	-9.47	-8.29	-8.59	-8.11	-8.82
Net Income	-8.09	-9.47	-8.29	-8.59	-8.11	-8.82
Net Income to Common	-8.09	-9.47	-8.29	-8.59	-8.11	-8.82
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	19	15	12	12	12	11
Shares Outstanding (Diluted)	19	15	12	12	12	11
Shares Change	32.11%	27.34%	2.11%	0.79%	5.81%	94.08%
EPS (Basic)	-0.43	-0.63	-0.70	-0.74	-0.70	-0.81
EPS (Diluted)	-0.43	-0.63	-0.70	-0.74	-0.70	-0.81
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Free Cash Flow	-7.37	-8.54	-6.47	-5.82	-6.22	-8.45
Free Cash Flow Per Share	-0.40	-0.56	-0.55	-0.50	-0.54	-0.78
EBITDA	-7.62	-8.85	-7.76	-8.2	-7.39	-8.04
D&A For EBITDA	0.56	0.74	0.76	0.75	0.72	0.7
EBIT	-8.18	-9.59	-8.52	-8.94	-8.11	-8.74

SEC Filings: 10-K · 10-Q